Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma

NCT00350961 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Cholangiocarcinoma

Interventions

DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Capecitabine

Sponsor

Rigshospitalet, Denmark

Collaborators

[object Object]